ARTICLE
Auteur(s) : Natsuko Ishida, Daisuke Watanabe, Tomoe
Kuhara, Hiromichi Takama, Yasuhiko Tamada, Yoshinari Matsumoto
Department of Dermatology, Aichi medical University,
Nagakute, Aichi, 480-1195 Japan
Herpes zoster is caused by the reactivation of varicella zoster
virus (VZV) from the nerve cell body in the sensory ganglia. It
predominantly affects immunocompromised people or those receiving
immunosuppressive drugs as well as elderly people [1]. Usually, the
clinical feature of herpes zoster is painful vesicular affecting a
single dermatome. However, atypical clinical presentations are
sometimes observed in immunosuppressed patients and transplant
recipients [2]. We report a case of solitary herpes zoster in
non-Hodgkin lymphoma patient.
A 72-year-old Japanese male who was receiving chemotherapy with
rituximab for a non-Hodgkin B cell lymphoma (Mantle cell lymphoma,
stage IV), presented with a painless necrotic vesicular on his
right femur. The lesion was accompanied by red halo of 15 mm
diameter (figures
1A,B). He had a history of recurrent varicella two years
previously, after receiving chemotherapy for 5 months. Tzanck test
revealed multinucleated giant cells. A clinical diagnosis of
herpes simplex virus (HSV) infection was made. A biopsy
specimen from the lesion showed multinucleated giant cells with a
ground-glass appearance of nuclei within hair follicles (figures 2A,B) and the
eccrine gland (figure
2D) The epidermis was peeled off during biopsy.
Immunohistochemical staining for VZV was positive in the same area
(figures 2C,E).
No HSV antigen was detected. PCR analysis from vesicular fluid
exhibited a positive band for VZV, but negative for HSV (data not
shown). Serum anti-VZV IgM and IgG titer was 0.19 and 3.8.
Antiviral treatment was started with 3000 mg of daily
valacyclovir for 3 weeks, but the lesion remained (figure 1C). VZV-DNA was
still positive from fluid of the lesion. Then external application
with vidarabin ointment was added. At day 40, the lesion was healed
and VZV-DNA was no longer detected (figure 1D). Serum anti-VZV
IgM and IgG titer at this time was 0.18 and 6.5.
Cutaneous eruptions caused by HSV1/2 and VZV represent common
dermatoses. In most cases, a correct diagnosis can be made by those
characteristic clinical features. But in some cases, especially in
patients with immunosuppression or with hematopoietic disorders,
cutaneous herpes infections can present with atypical clinical
presentations [1, 2]. It is also well known that HSV and VZV affect
not only the epidermal keratinocytes but also epithelial structures
of the adnexa. These involvements of the hair follicles and the
eccrine glands by herpesvirus infection are called herpes
folliculitis or herpetic sycosis. Herpes folliculitis is much more
commonly seen in VZV infections. Clinically, it often lacks
vesicles or pustules. Histopathological features of herpes
folliculitis often lack ballooning, multinucleated giant cells, but
have dense lymphoid infiltrates simulating malignant lymphoma [3].
Herpetic sycosis is a rare manifestation of VZV infection in HIV or
Hodgkin disease patients. In herpetic sycosis, epidermal damage by
herpetic infection was noted concomitantly with the eccrine
involvement [4].
To date, there are only two cases presenting solitary lesions by
herpes zoster. One is a painful nodule on the index finger of a
healthy woman showing intraepidermal blisters [5].
Histopathologically, the lesion shows intraepidermal blisters
containing degenerated keratinocytes and multinucleated giant
cells. Another case is herpetic sycosis without epidermal damage in
a Burkitt lymphoma patient [6]. In our case, atypical herpes zoster
presented as a solitary vesicular lesion, and histopathologically,
VZV infection was observed both in epithelial cells and hair
follicles. It was also interesting that the skin lesion in our case
was persistent in spite of antiviral treatment and that the
anti-VZV antibody titer was not elevated. Hematopoietic disorder
and anti-CD20 antibody therapy might be the reason why such an
atypical lesion occurred in this case.
Acknowledgements
Funding sources: none. Conflicts of interest: none.
References
1 Díaz-Ramón JL, Díaz-Pérez JL. Herpes simplex and
zoster. Eur J Dermatol 2008; 18: 108-11.
2 Ahmed AM, Brantley JS, Madkan V,
Mendoza N, Tyring SK. Managing herpes zoster in
immunocompromised patients. Herpes 2007; 14: 32-6.
3 Böer A, Herder N, Winter K, Falk T. Herpes
folliculitis: clinical, histopathological, and molecular pathologic
observations. Br J Dermatol 2006; 154: 743-6.
4 Sangueza OP, Gordon MD, White Jr. CR.
Subtle clues to the diagnosis of the herpesvirus by light
microscopy. Herpetic syringitis. Am J Dermatopathol 1995; 17:
163-8.
5 Izu K, Yamamoto O, Yasumoto S,
Hashimoto T, Sata T, Tokura Y. Herpes zoster
occurring as a solitary nodule on the index finger. Br J Dermatol
2004; 150: 365-6.
6 Alonso-Pérez A, Fraga J, Delgado Y,
Aragüés M, Nam-Cha S, García-Díez A. Nodular herpes
zoster with herpetic syringitis and no epidermal involvement in a
patient with Burkitt lymphoma. Am J Dermatopathol 2006; 28:
194-6.
|